Medicare Enrolled
Dr. Jaudat Mahmood
Pain Medicine · Kent, OH
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Consulting-driven
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Mahmood from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Mahmood?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Mahmood
Dr. Jaudat Mahmood is a pain medicine specialist in Kent, OH, with 12 years of NPI registration. Based on federal Medicare data, Dr. Mahmood performed 8,395 Medicare services across 1,484 unique beneficiaries.
Between the years covered by Open Payments, Dr. Mahmood received a total of $54,437 from 20 pharmaceutical and/or device companies across 167 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pain medicine. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Mahmood is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 12 years in practice
▲ Top 3% volume in OH
$54,437 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,395
Medicare services
Top 3% in OH for pain medicine
1,484
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~700 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Extended-release steroid injection (Zilretta) An injection of triamcinolone acetonide using a preservative-free, extended-release microsphere formulation. The dosage is measured in milligrams. |
3,200 | $13 | $31 |
| Contrast dye for imaging, lower concentration | 2,077 | $0 | $2 |
| Steroid injection (triamcinolone) A 10 mg injection of triamcinolone acetonide, a corticosteroid medication. This code specifies the drug and dosage administered. |
776 | $1 | $6 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
470 | $0 | $1 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
376 | $83 | $213 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
168 | $193 | $1,172 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
165 | $102 | $605 |
| Betamethasone steroid injection An injection containing a combination of betamethasone acetate and betamethasone sodium phosphate. |
136 | $5 | $21 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
120 | $90 | $386 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
79 | $117 | $320 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
75 | $61 | $146 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
69 | $207 | $1,263 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
65 | $107 | $649 |
| Fluoroscopic guidance for needle placement Use of real-time X-ray imaging to guide the precise placement of a needle during a medical procedure. |
64 | $86 | $303 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
56 | $153 | $676 |
| Joint injection, major joint Removal of fluid from a large joint and/or injection of medication into the joint space. |
51 | $57 | $291 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
49 | $192 | $704 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
42 | $60 | $855 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
38 | $236 | $1,213 |
| Trigger point injection, 3 or more muscles Injection of medication into three or more specific muscle trigger points to relieve pain. |
33 | $45 | $184 |
| Knee nerve block injection with imaging guidance An injection of anesthetic and/or steroid medication into a nerve branch of the knee, performed using imaging guidance to ensure accurate placement. |
33 | $196 | $870 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
33 | $211 | $2,413 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
33 | $42 | $331 |
| Injection, methylprednisolone acetate, 40 mg | 32 | $6 | $12 |
| Peripheral nerve neurostimulator electrode insertion A procedure to place an electrode through the skin into a peripheral nerve. This electrode is part of a neurostimulator system used to deliver electrical impulses. |
23 | $244 | $1,015 |
| Destruction of nerve branches of knee using imaging guidance | 23 | $130 | $1,609 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
22 | $81 | $213 |
| Destruction of peripheral nerve or branch | 21 | $69 | $475 |
| Suprascapular nerve injection An injection of anesthetic and/or steroid medication into the suprascapular nerve in the shoulder area. |
19 | $75 | $472 |
| Additional sacral spine nerve root injection with imaging An injection of anesthetic and/or steroid medication into an additional sacral spine nerve root level, guided by imaging. |
16 | $83 | $468 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
16 | $198 | $2,329 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
15 | $73 | $1,045 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$54,437
Total received (2019-2024)
Avg $9,073/year across 6 years
Top 5% in OH for pain medicine
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
20
Companies
167
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$47,242 (86.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,195 (13.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$25,041
2023
$23,036
2022
$1,197
2021
$325
2020
$1,675
2019
$3,163
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
SPR Therapeutics, Inc
$24,585
PAINTEQ LLC
$111
Averitas Pharma Inc.
$86
Medtronic, Inc.
$73
Vertos Medical, Inc.
$63
SI-BONE, INC.
$45
VERTEX PHARMACEUTICALS INCORPORATED
$22
Collegium Pharmaceutical, Inc.
$19
Abbott Laboratories
$19
Nevro Corp.
$17
Top 3 companies account for 99.0% of 2024 payments
All-time payments by company (2019-2024) ›
SPR Therapeutics, Inc
$48,419
Nevro Corp.
$3,658
Abbott Laboratories
$745
Vertos Medical, Inc.
$235
Medtronic, Inc.
$227
Boston Scientific Corporation
$134
PAINTEQ LLC
$131
Stryker Corporation
$131
Collegium Pharmaceutical, Inc.
$125
Insmed, Inc.
$125
Nalu Medical, Inc.
$114
Averitas Pharma Inc.
$86
SI-BONE, INC.
$71
BioDelivery Sciences International, Inc.
$66
Relievant Medsystems, Inc.
$59
DePuy Synthes Sales Inc.
$31
Pacira Therapeutics, Inc.
$24
VERTEX PHARMACEUTICALS INCORPORATED
$22
Pacira Pharmaceuticals Incorporated
$18
HydroCision, Inc.
$16
Top 3 companies account for 97.0% of all-time payments
Associated products mentioned in payments ›
Arikayce · BELBUCA · Belbuca · IFUSE IMPLANT · INFINION · INTELLIS · INTELLIS ADAPTIVESTIM · Intracept · Iovera · MONOVISC · Nalu Neurostimulation System · OCTRODE · Omnia · PAINTEQ · PROCLAIM · QUTENZA · SPINEJACK · SPRINT PNS System · Senza · Senza Spinal Cord Stimulation System · TenJet · XTAMPZA · Zilretta · mild Device Kit
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (87%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 5% for pain medicine in OH.
Geographic Context
Pain medicines within 10 mi
18
Per 100K population
11.2
County median income
$72,822
Nearest hospital
UNIVERSITY HOSPITALS PORTAGE MEDICAL CENTER
8.0 mi
8.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Mahmood is a mixed practice specialist, with above-average Medicare volume (top 3% in OH), with consulting-driven industry engagement in the top 5% of OH peers.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Mahmood experienced with extended-release steroid injection (zilretta)?
Based on Medicare claims data, Dr. Mahmood performed 3,200 extended-release steroid injection (zilretta) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Mahmood receive payments from pharmaceutical companies?
Yes. Dr. Mahmood received a total of $54,437 from 20 companies across 167 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Mahmood's costs compare to other pain medicines in Kent?
Dr. Mahmood's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Mahmood) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Pain Medicines in Kent
Browse pain medicines in Kent ranked by procedure volume and transparency data.
Highest volume
Top Pain Medicines in OH
Pain medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pain Medicines in OH
Which OH pain medicines receive the most from drug and device companies.
By company
SPR Therapeutics, Inc Payments to Doctors
See all physicians who received payments from SPR Therapeutics, Inc.
By company
Nevro Corp. Payments to Doctors
See all physicians who received payments from Nevro Corp.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology